A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myeloma
British Journal of Haematology, 05/09/2012
Bae J et al. – This study introduced a novel immunogenic HLA–A2–specific CS1239–247 peptide capable of inducing antigen–specific cytotoxic T lymphocytes (CTL) against multiple myeloma (MM) cells that will provide a framework for its application as a novel MM immunotherapy.



